ETH-45

N/A

Report date: 2023/01/08 14:04:00
NME

Base Information

Drug NameETH-45
Drug Alias NameETH-45
ClassificationSmall molecules > Nucleosides and nucleotide derivtives
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsPulmonary Alveolar Proteinosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEthris GmbH
China Registration ClassN/A

Develop Information

Active CompaniesEthris GmbH
Inactive CompaniesN/A
Active IndicationsPulmonary Alveolar Proteinosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A